Faisal Ghiath Sukhtian insider trades

Open-market stock purchases and sales by Faisal Ghiath Sukhtian, Director at Outlook Therapeutics, Inc, from SEC Form 4 filings since Oct 31, 2017.

Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -25%.

Recent trades

DateStockTradeValue
Jul 29, 2026OTLK Outlook Therapeutics, IncBought$100K
May 27, 2026OTLK Outlook Therapeutics, IncBought$50K
Oct 3, 2025OTLK Outlook Therapeutics, IncBought (not open market)—

Companies traded

  • OTLK Outlook Therapeutics, Inc: 6 buys, last Jul 29, 2026
  • ONS Oncobiologics, Inc: other filings, last Oct 31, 2017

Get free alerts when Faisal Ghiath Sukhtian files a new trade →